Literature DB >> 1785690

Continuous spectrophotometric assays for dopamine beta-monooxygenase based on two novel electron donors: N,N-dimethyl-1,4-phenylenediamine and 2-aminoascorbic acid.

K Wimalasena1, D S Wimalasena.   

Abstract

Based on the novel chromophoric electron donors, N,N-dimethyl-1,4-phenylenediamine (DMPD) and 2-amino-2-deoxy-L-ascorbic acid (2-aminoascorbic acid), two sensitive, convenient, and continuous spectrophotometric assays for dopamine beta-monooxygenase (EC 1.14.17.1) are described. Both, DMPD and 2-aminoascorbic acid are kinetically and stoichiometrically well-behaved electron donors for dopamine beta-monooxygenase with kinetic parameters comparable to the most efficient physiological electron donor, ascorbic acid. During dopamine beta-monooxygenase turnover, DMPD is converted to its chromophoric cation radical which is stable under the standard assay conditions. The rate of the enzyme-dependent formation of DMPD cation radical under standard assay conditions could easily be followed at 515 nm with high accuracy and reproducibility. Similarly, dopamine beta-monooxygenase-mediated oxidation of 2-aminoascorbic acid results in the formation of the known, stable chromophoric product, 2,2'-nitrilodi-2(2')-deoxy-L-ascorbic acid (red pigment), which has a very strong absorption maximum at 385 nm. Both the above assays are superior to the existing assays in their convenience, reproducibility, and sensitivity for routine kinetic analysis of dopamine beta-monooxygenase and may be adopted as a simple color test for the enzyme. We propose that the above assays could also be adopted to design continuous and sensitive spectrophotometric assays for ascorbate oxidase, peptidyl alpha-amidating monooxygenase, and the chromaffin granule electron transport protein, cytochrome b561, due to their remarkable similarity to dopamine beta-monooxygenase in the chemistry of catalysis with regard to the electron donor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1785690     DOI: 10.1016/0003-2697(91)90404-h

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.

Authors:  D Shyamali Wimalasena; Samantha P Jayatillake; Donovan C Haines; Kandatege Wimalasena
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

2.  Anion- and pH-dependent activation of the soluble form of dopamine beta-hydroxylase.

Authors:  Ole Terland; Torgeir Flatmark
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

3.  Determination of Dopamine-β-hydroxylase Activity in Human Serum Using UHPLC-PDA Detection.

Authors:  Toyanji Joseph Punchaichira; Smita Neelkanth Deshpande; B K Thelma
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

4.  NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis.

Authors:  C Li; C D Oldham; S W May
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Expression of human dopamine beta-hydroxylase in Drosophila Schneider 2 cells.

Authors:  B Li; S Tsing; A H Kosaka; B Nguyen; E G Osen; C Bach; H Chan; J Barnett
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

6.  A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.

Authors:  Eugene Gonzalez-Lopez; Yuka Kawasawa-Imamura; Lijun Zhang; Xuemei Huang; Walter A Koltun; Matthew D Coates; Kent E Vrana
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.